Abbott faces US criminal probe over baby formula: WSJ
ABBOTT Laboratories’ Michigan plant, which was at the centre of the US baby formula shortage last year, is being investigated by the Justice Department, the Wall Street Journal reported on Friday (Jan 20).
Attorneys with the Justice Department’s consumer-protection branch are conducting the criminal investigation, the report said, citing people familiar with the matter.
“DOJ has informed us of its investigation and we’re cooperating fully,” an Abbott spokesman told Reuters.
In February 2022, Abbott, the biggest US supplier of baby formula, recalled Similac and other infant formula products produced at the Michigan facility after reports of bacterial infections in babies who had consumed products made there.
The shutdown of the plant and subsequent product recalls exacerbated a baby formula shortage in the United States that began due to pandemic-induced supply chain issues. REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance
Suntec Reit Q1 DPU down 13% to S$0.01511 in absence of capital distribution
US: Wall St opens lower as Meta Platforms, economic data weigh